Hemolysis, pump thrombus, and neurologic events in continuous-flow left ventricular assist device recipients.

[1]  S. Pinney,et al.  Failed repeated thrombolysis requiring left ventricular assist device pump exchange , 2013, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

[2]  Dee Dee Wang,et al.  Successful treatment of a continuous flow left ventricular assist device thrombosis with eptifibatide. , 2012, ASAIO journal (1992).

[3]  Nir Uriel,et al.  Development of a novel echocardiography ramp test for speed optimization and diagnosis of device thrombosis in continuous-flow left ventricular assist devices: the Columbia ramp study. , 2012, Journal of the American College of Cardiology.

[4]  S. Russell,et al.  The Spectrum of Complications Following Left Ventricular Assist Device Placement , 2012, Journal of cardiac surgery.

[5]  G. Bhat,et al.  Are Blood Stream Infections Associated With an Increased Risk of Hemorrhagic Stroke in Patients With a Left Ventricular Assist Device? , 2012, ASAIO journal.

[6]  R. Autschbach,et al.  Low stroke rate and few thrombo-embolic events after HeartMate II implantation under mild anticoagulation. , 2012, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[7]  P. Eckman,et al.  Successful treatment of early thrombosis of HeartWare left ventricular assist device with intraventricular thrombolytics. , 2012, The Annals of thoracic surgery.

[8]  Ranjit John,et al.  Bleeding and Thrombosis in Patients With Continuous-Flow Ventricular Assist Devices , 2012, Circulation.

[9]  Klaus Görlinger,et al.  Coagulation management in patients undergoing mechanical circulatory support. , 2012, Best practice & research. Clinical anaesthesiology.

[10]  A. Boyle,et al.  Lessons learned from experience with over 100 consecutive HeartMate II left ventricular assist devices. , 2011, The Annals of thoracic surgery.

[11]  Adrian F Hernandez,et al.  Mechanisms of bleeding and approach to patients with axial-flow left ventricular assist devices. , 2011, Circulation. Heart failure.

[12]  M. Morshuis,et al.  Echocardiography Can Be More Sensitive than Thoracic Computed Tomography in Detecting a Thrombus in the Inflow Cannula of a Continuous Left Ventricular Assist Device , 2011, Echocardiography.

[13]  S. Spiliopoulos,et al.  HeartMate II ventricular assist device thrombosis-an echocardiographic approach to diagnosis: can Doppler evaluation of flow be useful? , 2011, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.

[14]  M. Slaughter.  Hematologic Effects of Continuous Flow Left Ventricular Assist Devices , 2010, Journal of cardiovascular translational research.

[15]  S. Russell,et al.  Post-operative heparin may not be required for transitioning patients with a HeartMate II left ventricular assist system to long-term warfarin therapy. , 2010, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[16]  M. Firstenberg,et al.  Profound thrombocytopenia with glycoprotein IIb/IIIa inhibitors plus heparin for pump thrombus. , 2008, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[17]  Andrew Boyle,et al.  Improved survival and decreasing incidence of adverse events with the HeartMate II left ventricular assist device as bridge-to-transplant therapy. , 2008, The Annals of thoracic surgery.

[18]  Joel D. Graham,et al.  Fibrinolytic Activation During Long-term Support With the Heartmate II Left Ventricular Assist Device , 2008, ASAIO journal.

[19]  J F Antaki,et al.  HeartMate II left ventricular assist system: from concept to first clinical use. , 2001, The Annals of thoracic surgery.

[20]  M. Bristow,et al.  Economic impact of heart failure in the United States: time for a different approach. , 1994, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[21]  S. Kurien,et al.  Anticoagulation and bleeding in patients with ventricular assist devices: walking the tightrope. , 2012, AACN advanced critical care.

[22]  Khurram Shahzad,et al.  Pre-operative and post-operative risk factors associated with neurologic complications in patients with advanced heart failure supported by a left ventricular assist device. , 2012, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[23]  Biswajit Kar,et al.  First clinical use of the redesigned HeartMate II left ventricular assist system in the United States: a case report. , 2004, Texas Heart Institute journal.